Ritchie Robert F, Palomaki Glenn E, Neveux Louis M, Navolotskaia Olga, Ledue Thomas B, Craig Wendy Y
Foundation for Blood Research, Scarborough, Maine 04074, USA.
J Clin Lab Anal. 2004;18(1):1-8. doi: 10.1002/jcla.10100.
The two serum proteins of the complement cascade in the highest concentrations, C3 and C4, respond to various conditions in much the same manner as do other positive acute-phase proteins. A major difference is that they are relatively sluggish in response to cytokine drive, requiring several days rather than hours to be detectably elevated by serial measurements. As with other acute-phase proteins, there are many processes that up- or down-regulate synthesis, including infection or inflammation, hepatic failure, and immune-complex formation. Clinicians may find it difficult to distinguish among these processes, because they often occur simultaneously. The situation is further complicated by genetic polymorphism, with rare instances of markedly reduced synthesis and circulating levels, and consequent vulnerability to infection. C3 and C4 are measured for clinical purposes to help define certain rheumatic and immunologically mediated renal diseases. Interpreting the measured blood levels of these two components requires one to consider the intensity of the inflammatory drive, the timing of the suspected clinical process, the production of complement-consuming immune complexes, and the possible existence of benign circumstances. In this fifth article in a series, reference ranges for serum levels of two complement proteins (C3 and C4) are examined. The study is based on a cohort of over 55,000 Caucasian individuals from northern New England, who were tested in our laboratory in 1994-1999. Measurements were standardized against certified reference material (CRM) 470/reference preparation for proteins in human serum (RPPHS), and analyzed using a previously described statistical approach. Individuals with unequivocal laboratory evidence of inflammation (C-reactive protein of 10 mg/L or higher) were excluded. Our results show that the levels of C3 and C4 change little during life and between the sexes, except that they increase slightly and then fall after age 20 in males and at about age 45 in females. When values were expressed as multiples of the age- and gender-specific median levels, the resulting distributions fitted a log-Gaussian distribution well over a broad range. When patient data are normalized in this manner, the distribution parameters can be used to assign a centile corresponding to an individual's measurement, thus simplifying interpretation.
补体级联反应中浓度最高的两种血清蛋白C3和C4,与其他阳性急性期蛋白对各种情况的反应方式大致相同。一个主要区别在于,它们对细胞因子驱动的反应相对迟缓,通过连续测量可检测到升高需要数天而非数小时。与其他急性期蛋白一样,有许多过程会上调或下调其合成,包括感染或炎症、肝功能衰竭以及免疫复合物形成。临床医生可能难以区分这些过程,因为它们常常同时发生。遗传多态性使情况更加复杂,存在合成和循环水平显著降低的罕见情况,从而导致易受感染。出于临床目的检测C3和C4有助于诊断某些风湿性和免疫介导的肾脏疾病。解读这两种成分的测量血水平需要考虑炎症驱动的强度、疑似临床过程的时间、消耗补体的免疫复合物的产生以及是否存在良性情况。在本系列的第五篇文章中,研究了两种补体蛋白(C3和C4)的血清水平参考范围。该研究基于来自新英格兰北部的55000多名白种人的队列,他们于1994年至1999年在我们实验室接受检测。测量针对人血清中蛋白质的认证参考物质(CRM)470/参考制剂(RPPHS)进行标准化,并使用先前描述的统计方法进行分析。排除有明确实验室炎症证据(C反应蛋白为10mg/L或更高)的个体。我们的结果表明,C3和C4的水平在一生中以及男女之间变化不大,只是男性在20岁后略有升高然后下降,女性在约45岁时如此。当将数值表示为年龄和性别特异性中位数水平的倍数时,所得分布在很宽范围内很好地拟合对数高斯分布。当以这种方式对患者数据进行标准化时,分布参数可用于为个体测量值指定百分位数,从而简化解读。